SKI Market

A+| A| A-|

Indian Indices

Sensex

74,207.24 -2,496.89
( -3.26%)

Global Indices

Nasdaq

46,043.89 -202.27
(-0.44%)

Dow Jones

6,628.50 -17.20
(-0.26%)

Hang Seng

53,297.18 -1,942.22
(-3.52%)

Nikkei 225

10,057.93 -247.36
(-2.40%)

Forex

USD-INR

92.39 0.06
(0.06%)

EUR-INR

106.38 0.46
(0.44%)

GBP-INR

123.15 0.52
(0.42%)

JPY-INR

0.58 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

222.5

49.66

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

Coral Laboratories standalone net profit declines 54.72% in the December 2025 quarter

Feb 13,2026

Net profit of Coral Laboratories declined 54.72% to Rs 2.78 crore in the quarter ended December 2025 as against Rs 6.14 crore during the previous quarter ended December 2024. Sales declined 6.22% to Rs 21.56 crore in the quarter ended December 2025 as against Rs 22.99 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	21.56	22.99	-6
OPM %	8.81	27.45	-
PBDT	4.39	8.81	-50
PBT	3.70	8.31	-55
NP	2.78	6.14	-55

74,207.24 -2,496.89 ( -3.26%)

46,043.89 -202.27 (-0.44%)

6,628.50 -17.20 (-0.26%)

53,297.18 -1,942.22 (-3.52%)

10,057.93 -247.36 (-2.40%)

92.39 0.06 (0.06%)

106.38 0.46 (0.44%)

123.15 0.52 (0.42%)

0.58 0.00 (0.14%)